Fund Overview of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth
-
₹167.2 CrAUM
-
₹22.09NAV
-
0.54%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 4.18% | NA | 6.12% |
| 6 Months | 6.03% | NA | 12.92% |
| 1 Year | 14.47% | 14.47% | 6.04% |
| 2 Years | 27.90% | 13.09% | 24.93% |
| 3 Years | 76.52% | 20.85% | 25.71% |
| 5 Years | 84.68% | 13.05% | 19.91% |
Asset Allocation
equities
99.50%debt instruments
0.26%other assets or cash equivalents
0.24%Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth is one Equity mutual fund offered by Edelweiss Mutual Fund. Launched on 26 Oct 2020, the fund aims Long Term Capital appreciation. Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking error. It manages assets worth ₹167.2 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.54%. Fund Manager Manager Education Fund Manager Manager EducationAbout Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth
The portfolio allocation consists of 99.50% in equities, 0.26% in debt instruments, 0.24% in other assets or cash equivalents.Managed by Amit Vora, it has delivered a return of 14.47% in the last year, a total return since inception of 15.40%.
People planning wealth creation often analyze different best sip in order to create goal-based financial stability.
Key Metrics of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth
-
Standard Deviation12.40%
-
Sharpe Ratio0.96%
-
Alpha-0.05%
-
Beta0.70%
Fund Details
|
|
Top Performing Mutual Funds
More funds from Edelweiss Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-growth
|
₹167 | 6.70% | 4.04% | 5.75% | 13.85% | 20.19% |
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw
|
₹167 | 6.70% | 4.04% | 5.75% | 13.85% | 20.19% |
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-idcw
|
₹167 | 6.75% | 4.18% | 6.03% | 14.47% | 20.85% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹537.83 | 23.67% | 13.51% | 14.97% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹603.39 | 24.79% | 14.54% | 16.00% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹116.14 | 23.67% | 13.51% | 14.97% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹165.14 | 24.79% | 14.54% | 16.00% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹41.50 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹45.01 | 29.60% | 17.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹24.21 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹27.18 | 29.60% | 17.49% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹455.80 | 26.16% | 15.84% | 12.77% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹526.21 | 27.48% | 17.07% | 14.01% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.50% | ₹20.19 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.25% | ₹19.68 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.73% | ₹19.62 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.45% | ₹18.96 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.98% | ₹18.75 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.16% | ₹18.74 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.16% | ₹18.74 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.90% | ₹18.19 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.89% | ₹17.72 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.89% | ₹17.72 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 6.83% | ₹11.99 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 6.97% | ₹11.91 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.77% | ₹11.21 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 6.01% | ₹10.51 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 6.27% | ₹10.47 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.92% | ₹10.39 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.14% | ₹10.31 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.14% | ₹10.31 Cr |
| Cipla Ltd | Healthcare | 6.14% | ₹10.17 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.17% | ₹10.04 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.17% | ₹10.04 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.73% | ₹10.03 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.69% | ₹9.96 Cr |
| Cipla Ltd | Healthcare | 5.66% | ₹9.94 Cr |
| Cipla Ltd | Healthcare | 6.05% | ₹9.84 Cr |
| Cipla Ltd | Healthcare | 6.05% | ₹9.84 Cr |
| Cipla Ltd | Healthcare | 5.84% | ₹9.80 Cr |
| Cipla Ltd | Healthcare | 5.84% | ₹9.80 Cr |
| Cipla Ltd | Healthcare | 5.69% | ₹9.71 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.75% | ₹9.65 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.75% | ₹9.65 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.72% | ₹9.56 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.59% | ₹9.35 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.54% | ₹9.30 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.54% | ₹9.30 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.41% | ₹9.24 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.51% | ₹9.12 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.18% | ₹9.09 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.17% | ₹9.04 Cr |
| Cipla Ltd | Healthcare | 5.14% | ₹9.00 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.32% | ₹8.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.32% | ₹8.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.35% | ₹8.92 Cr |
| Cipla Ltd | Healthcare | 5.33% | ₹8.90 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.06% | ₹8.89 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.30% | ₹8.86 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.30% | ₹8.84 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.28% | ₹8.73 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.08% | ₹8.68 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.31% | ₹8.64 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.31% | ₹8.64 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.05% | ₹8.63 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.15% | ₹8.59 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.19% | ₹8.59 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.25% | ₹8.54 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.25% | ₹8.54 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.08% | ₹8.50 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.09% | ₹8.28 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.09% | ₹8.28 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 4.98% | ₹8.24 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.71% | ₹8.24 Cr |
| Cipla Ltd | Healthcare | 4.84% | ₹8.09 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.81% | ₹8.08 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.81% | ₹8.08 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.76% | ₹7.96 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.84% | ₹7.87 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.84% | ₹7.87 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.71% | ₹7.85 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.47% | ₹7.84 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.59% | ₹7.84 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 4.52% | ₹7.56 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 4.25% | ₹7.43 Cr |
| Lupin Ltd | Healthcare | 4.13% | ₹6.91 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.93% | ₹6.90 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 4.12% | ₹6.87 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 4.02% | ₹6.86 Cr |
| Lupin Ltd | Healthcare | 3.90% | ₹6.83 Cr |
| Lupin Ltd | Healthcare | 3.85% | ₹6.43 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.75% | ₹6.30 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.75% | ₹6.30 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.80% | ₹6.19 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.80% | ₹6.19 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.46% | ₹6.06 Cr |
| Lupin Ltd | Healthcare | 3.53% | ₹6.02 Cr |
| Lupin Ltd | Healthcare | 3.42% | ₹6.01 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.55% | ₹5.94 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.45% | ₹5.80 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.45% | ₹5.80 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.49% | ₹5.68 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.49% | ₹5.68 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.34% | ₹5.58 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.17% | ₹5.57 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.25% | ₹5.56 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.39% | ₹5.51 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.39% | ₹5.51 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.31% | ₹5.48 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.12% | ₹5.46 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.18% | ₹5.34 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.18% | ₹5.34 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.03% | ₹5.18 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.95% | ₹5.18 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.18 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.18 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.10% | ₹5.13 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.10 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 2.91% | ₹5.09 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.88% | ₹5.06 Cr |
| Lupin Ltd | Healthcare | 3.11% | ₹5.05 Cr |
| Lupin Ltd | Healthcare | 3.11% | ₹5.05 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.98% | ₹4.97 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.04% | ₹4.94 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.04% | ₹4.94 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 2.96% | ₹4.94 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 2.95% | ₹4.93 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.89% | ₹4.93 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.90% | ₹4.87 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.90% | ₹4.87 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.94% | ₹4.87 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.77% | ₹4.63 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 2.79% | ₹4.62 Cr |
| Laurus Labs Ltd | Healthcare | 2.55% | ₹4.46 Cr |
| Laurus Labs Ltd | Healthcare | 2.59% | ₹4.42 Cr |
| Laurus Labs Ltd | Healthcare | 2.37% | ₹4.16 Cr |
| Laurus Labs Ltd | Healthcare | 2.44% | ₹4.08 Cr |
| Laurus Labs Ltd | Healthcare | 2.41% | ₹4.02 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.28% | ₹3.98 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.37% | ₹3.96 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.24% | ₹3.91 Cr |
| Laurus Labs Ltd | Healthcare | 2.30% | ₹3.86 Cr |
| Laurus Labs Ltd | Healthcare | 2.30% | ₹3.86 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 2.20% | ₹3.84 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 2.29% | ₹3.83 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.27% | ₹3.80 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.15% | ₹3.77 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.25% | ₹3.75 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.23% | ₹3.73 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.23% | ₹3.72 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.10% | ₹3.68 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.22% | ₹3.68 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 2.07% | ₹3.63 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 2.12% | ₹3.62 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.11% | ₹3.61 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.10% | ₹3.59 Cr |
| Laurus Labs Ltd | Healthcare | 2.14% | ₹3.55 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.13% | ₹3.55 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.06% | ₹3.51 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.15% | ₹3.49 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.15% | ₹3.49 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.10% | ₹3.48 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.98% | ₹3.47 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 2.07% | ₹3.46 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.08% | ₹3.45 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.05% | ₹3.44 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.05% | ₹3.44 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.96% | ₹3.43 Cr |
| Laurus Labs Ltd | Healthcare | 2.10% | ₹3.42 Cr |
| Laurus Labs Ltd | Healthcare | 2.10% | ₹3.42 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.03% | ₹3.41 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.03% | ₹3.41 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.08% | ₹3.38 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.08% | ₹3.38 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.88% | ₹3.29 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.02% | ₹3.28 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.02% | ₹3.28 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.94% | ₹3.26 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.94% | ₹3.26 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.99% | ₹3.23 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.99% | ₹3.23 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.93% | ₹3.23 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.82% | ₹3.20 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.96% | ₹3.19 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.96% | ₹3.19 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.82% | ₹3.18 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.87% | ₹3.13 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.78% | ₹3.12 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.77% | ₹3.11 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.76% | ₹3.09 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.81% | ₹3.09 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.84% | ₹3.08 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.84% | ₹3.08 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.83% | ₹3.02 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.77% | ₹3.02 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.76% | ₹3.00 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.78% | ₹2.99 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.78% | ₹2.99 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.75% | ₹2.99 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.79% | ₹2.99 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.80% | ₹2.99 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.78% | ₹2.98 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.78% | ₹2.98 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.77% | ₹2.98 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.77% | ₹2.98 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.80% | ₹2.92 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.80% | ₹2.92 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.72% | ₹2.88 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.76% | ₹2.86 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.76% | ₹2.86 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.62% | ₹2.85 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.69% | ₹2.83 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.69% | ₹2.83 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.71% | ₹2.82 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.64% | ₹2.80 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.64% | ₹2.74 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.64% | ₹2.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.59% | ₹2.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.59% | ₹2.66 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.58% | ₹2.66 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.58% | ₹2.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.62% | ₹2.63 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.62% | ₹2.63 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.48% | ₹2.59 Cr |
| Biocon Ltd | Healthcare | 1.55% | ₹2.58 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.47% | ₹2.58 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.53% | ₹2.57 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.56% | ₹2.55 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.56% | ₹2.55 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.44% | ₹2.52 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.42% | ₹2.48 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.52% | ₹2.47 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.52% | ₹2.47 Cr |
| Biocon Ltd | Healthcare | 1.41% | ₹2.46 Cr |
| Biocon Ltd | Healthcare | 1.39% | ₹2.45 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.46% | ₹2.44 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.47% | ₹2.44 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.47% | ₹2.44 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.45% | ₹2.43 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.42% | ₹2.43 Cr |
| Biocon Ltd | Healthcare | 1.46% | ₹2.42 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.37% | ₹2.40 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.44% | ₹2.40 Cr |
| Biocon Ltd | Healthcare | 1.40% | ₹2.39 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.43% | ₹2.39 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.44% | ₹2.38 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.44% | ₹2.38 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.41% | ₹2.36 Cr |
| Biocon Ltd | Healthcare | 1.40% | ₹2.33 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹2.33 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.38% | ₹2.31 Cr |
| Biocon Ltd | Healthcare | 1.37% | ₹2.30 Cr |
| Biocon Ltd | Healthcare | 1.37% | ₹2.30 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.31% | ₹2.30 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.36% | ₹2.28 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.36% | ₹2.27 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.32% | ₹2.26 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.32% | ₹2.25 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.37% | ₹2.23 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.37% | ₹2.23 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.33% | ₹2.23 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.33% | ₹2.23 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.33% | ₹2.22 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.27% | ₹2.22 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.32% | ₹2.21 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.25% | ₹2.20 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.31% | ₹2.20 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.31% | ₹2.20 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.25% | ₹2.19 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.32% | ₹2.19 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.24% | ₹2.18 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹2.16 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹2.16 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.16 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.27% | ₹2.12 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.26% | ₹2.11 Cr |
| Biocon Ltd | Healthcare | 1.30% | ₹2.11 Cr |
| Biocon Ltd | Healthcare | 1.30% | ₹2.11 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.29% | ₹2.11 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.29% | ₹2.11 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.10 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.22% | ₹2.09 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.07 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.07 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.25% | ₹2.06 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.23% | ₹2.06 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.22% | ₹2.05 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.22% | ₹2.05 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.19% | ₹2.03 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.15% | ₹2.02 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.19% | ₹1.99 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.17% | ₹1.93 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.15% | ₹1.92 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.15% | ₹1.92 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.18% | ₹1.92 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.18% | ₹1.92 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 1.07% | ₹1.87 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.12% | ₹1.86 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.03% | ₹1.80 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.09% | ₹1.77 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.09% | ₹1.77 Cr |
| Gland Pharma Ltd | Healthcare | 1.07% | ₹1.77 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.06% | ₹1.77 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.01% | ₹1.77 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.09% | ₹1.77 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.09% | ₹1.77 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.05% | ₹1.76 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.06% | ₹1.76 Cr |
| Gland Pharma Ltd | Healthcare | 1.05% | ₹1.71 Cr |
| Gland Pharma Ltd | Healthcare | 1.05% | ₹1.71 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.01% | ₹1.70 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.01% | ₹1.70 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.99% | ₹1.70 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 1.04% | ₹1.69 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 1.04% | ₹1.69 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 0.98% | ₹1.67 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 0.95% | ₹1.66 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.99% | ₹1.66 Cr |
| Gland Pharma Ltd | Healthcare | 0.98% | ₹1.65 Cr |
| Gland Pharma Ltd | Healthcare | 0.98% | ₹1.65 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 0.94% | ₹1.65 Cr |
| Gland Pharma Ltd | Healthcare | 0.98% | ₹1.63 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.98% | ₹1.62 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.96% | ₹1.61 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.96% | ₹1.61 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.94% | ₹1.60 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.91% | ₹1.60 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.97% | ₹1.60 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 0.96% | ₹1.60 Cr |
| Gland Pharma Ltd | Healthcare | 0.91% | ₹1.59 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.96% | ₹1.59 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.90% | ₹1.58 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.94% | ₹1.55 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.89% | ₹1.55 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 0.93% | ₹1.55 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.88% | ₹1.55 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.88% | ₹1.55 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.88% | ₹1.54 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.90% | ₹1.54 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 0.92% | ₹1.53 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 0.91% | ₹1.53 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.90% | ₹1.52 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.90% | ₹1.52 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.91% | ₹1.52 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.90% | ₹1.50 Cr |
| Gland Pharma Ltd | Healthcare | 0.85% | ₹1.50 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 0.86% | ₹1.50 Cr |
| Syngene International Ltd | Healthcare | 0.90% | ₹1.50 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.89% | ₹1.49 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 0.87% | ₹1.46 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.87% | ₹1.45 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.86% | ₹1.45 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.86% | ₹1.45 Cr |
| Gland Pharma Ltd | Healthcare | 0.85% | ₹1.45 Cr |
| Gland Pharma Ltd | Healthcare | 0.87% | ₹1.45 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.87% | ₹1.45 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.88% | ₹1.44 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.88% | ₹1.44 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.85% | ₹1.43 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.86% | ₹1.40 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.86% | ₹1.40 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.84% | ₹1.39 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.38 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.38 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.81% | ₹1.38 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.82% | ₹1.37 Cr |
| Syngene International Ltd | Healthcare | 0.81% | ₹1.36 Cr |
| Syngene International Ltd | Healthcare | 0.81% | ₹1.36 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.36 Cr |
| Syngene International Ltd | Healthcare | 0.77% | ₹1.35 Cr |
| Syngene International Ltd | Healthcare | 0.79% | ₹1.34 Cr |
| Piramal Pharma Ltd | Healthcare | 0.81% | ₹1.32 Cr |
| Piramal Pharma Ltd | Healthcare | 0.81% | ₹1.32 Cr |
| Syngene International Ltd | Healthcare | 0.80% | ₹1.31 Cr |
| Syngene International Ltd | Healthcare | 0.80% | ₹1.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.80% | ₹1.30 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.80% | ₹1.30 Cr |
| Piramal Pharma Ltd | Healthcare | 0.73% | ₹1.29 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.73% | ₹1.29 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.73% | ₹1.29 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.76% | ₹1.28 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.76% | ₹1.28 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.71% | ₹1.25 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.74% | ₹1.24 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.74% | ₹1.24 Cr |
| Global Health Ltd | Healthcare | 0.75% | ₹1.23 Cr |
| Global Health Ltd | Healthcare | 0.75% | ₹1.23 Cr |
| Global Health Ltd | Healthcare | 0.74% | ₹1.22 Cr |
| Global Health Ltd | Healthcare | 0.73% | ₹1.22 Cr |
| Global Health Ltd | Healthcare | 0.73% | ₹1.22 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.75% | ₹1.22 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.75% | ₹1.22 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.72% | ₹1.21 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.70% | ₹1.19 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.71% | ₹1.18 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.70% | ₹1.18 Cr |
| Piramal Pharma Ltd | Healthcare | 0.69% | ₹1.17 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.72% | ₹1.17 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.72% | ₹1.17 Cr |
| Global Health Ltd | Healthcare | 0.66% | ₹1.15 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.64% | ₹1.13 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.65% | ₹1.11 Cr |
| Piramal Pharma Ltd | Healthcare | 0.63% | ₹1.10 Cr |
| Piramal Pharma Ltd | Healthcare | 0.66% | ₹1.10 Cr |
| Global Health Ltd | Healthcare | 0.64% | ₹1.09 Cr |
| Global Health Ltd | Healthcare | 0.62% | ₹1.08 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.63% | ₹1.05 Cr |
| Syngene International Ltd | Healthcare | 0.61% | ₹1.02 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.58% | ₹1.02 Cr |
| Global Health Ltd | Healthcare | 0.61% | ₹1.01 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.59% | ₹1.00 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.59% | ₹1.00 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.58% | ₹0.97 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.58% | ₹0.97 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.58% | ₹0.97 Cr |
| Global Health Ltd | Healthcare | 0.55% | ₹0.91 Cr |
| Syngene International Ltd | Healthcare | 0.52% | ₹0.90 Cr |
| Others Cblo | Unspecified | 0.49% | ₹0.86 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.51% | ₹0.83 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.51% | ₹0.83 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.48% | ₹0.80 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 0.47% | ₹0.80 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.44% | ₹0.77 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.45% | ₹0.77 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.46% | ₹0.74 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.46% | ₹0.74 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.42% | ₹0.74 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.44% | ₹0.73 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.71 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.71 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.70 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.36% | ₹0.63 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.34% | ₹0.60 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.34% | ₹0.58 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.34% | ₹0.58 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.34% | ₹0.58 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.54 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.31% | ₹0.53 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.53 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.52 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.52 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.31% | ₹0.52 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.31% | ₹0.51 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.31% | ₹0.51 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.30% | ₹0.49 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.29% | ₹0.48 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.28% | ₹0.46 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.28% | ₹0.46 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.27% | ₹0.45 Cr |
| Others Cblo | Unspecified | 0.27% | ₹0.45 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.27% | ₹0.45 Cr |
| Others Cblo | Unspecified | 0.26% | ₹0.43 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.24% | ₹0.43 Cr |
| Others Cblo | Unspecified | 0.25% | ₹0.42 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.25% | ₹0.41 Cr |
| Net Receivables | Unspecified | 0.24% | ₹0.39 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.21% | ₹0.36 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.21% | ₹0.36 Cr |
| Net Receivables | Unspecified | 0.17% | ₹0.30 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.28 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.17% | ₹0.28 Cr |
| Others Cblo | Unspecified | 0.16% | ₹0.28 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.28 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.27 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.27 Cr |
| Others Cblo | Unspecified | 0.15% | ₹0.26 Cr |
| Others Cblo | Unspecified | 0.15% | ₹0.26 Cr |
| Others Cblo | Unspecified | 0.15% | ₹0.26 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.14% | ₹0.24 Cr |
| Net Receivables | Unspecified | 0.10% | ₹0.23 Cr |
| Net Receivables | Unspecified | 0.10% | ₹0.23 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.22 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.21 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.21 Cr |
| Others Cblo | Unspecified | 0.11% | ₹0.18 Cr |
| Others Cblo | Unspecified | 0.11% | ₹0.18 Cr |
| Waters Corporation (wat) | Healthcare | 0.09% | ₹0.15 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Net Payables | Unspecified | -0.01% | ₹-0.03 Cr |
| Net Payables | Unspecified | -0.05% | ₹-0.08 Cr |
| Net Payables | Unspecified | -0.05% | ₹-0.08 Cr |
| Net Payables | Unspecified | -0.09% | ₹-0.13 Cr |
| Net Payables | Unspecified | -0.10% | ₹-0.14 Cr |
| Net Payables | Unspecified | -0.38% | ₹-0.69 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹45.01 | 29.60% | 17.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.18 | 29.60% | 17.49% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹526.21 | 27.48% | 17.07% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹365.60 | 27.48% | 17.07% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.15 | 27.16% | 16.47% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.40 | 27.16% | 16.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹41.50 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹24.21 | 28.51% | 16.46% | - |
| SBI Healthcare Opportunities Fund-growth |
₹455.80 | 26.16% | 15.84% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹287.13 | 26.16% | 15.84% | - |
Frequently Asked Questions
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth
What is the current AUM of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth?
As of Tue Mar 31, 2026, Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth manages assets worth ₹167.2 crore
How has Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth performed recently?
- 3 Months: 4.18%
- 6 Months: 6.03%
What is the long-term performance of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth?
- 3 Years CAGR: 20.85%
- 5 Years CAGR: 13.05%
- Since Inception: 15.40%
What is the portfolio composition of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth?
Equity: 99.50%, Debt: 0.26%, Others: 0.24%.
Who manages Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth?
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth is managed by Amit Vora from Edelweiss Mutual Fund.
What is the market-cap allocation of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth?
Large Cap: 71.68%, Mid Cap: 23.99%, Small Cap: 4.33%.
Which are the top companies Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 11.50% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.25% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.73% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.45% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.98% of the fund's portfolio
Which are the major sectors Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth focuses on?
- Healthcare – 997.87% of the fund's portfolio
- Unspecified – 2.04% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





